Washington to receive share of $62 million consumer protection settlement with Zyprexa manufacturer
OLYMPIA -- Attorney General McKenna today announced that he, along with 33 other attorneys general, reached a record $62 million settlement with Eli Lilly and Company concerning allegations that the company marketed its antipsychotic drug Zyprexa for unapproved uses. The settlement is the largest multistate consumer protection pharmaceutical settlement and follows closely on the heels of the states’ $58 million agreement with Merck in May 2008 regarding its product Vioxx.
Other Languages